SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Xehetasun bibliografikoak
Egile nagusia:	Meem, Manila
Beste egile batzuk:	Akter, Dr. Raushanara
Formatua:	Thesis
Hizkuntza:	English
Argitaratua:	Brac University 2023
Gaiak:	Cancer SHP2 inhibitors Targeted therapy Catalytic inhibitor Allosteric inhibitor. Cancer research.
Sarrera elektronikoa:	http://hdl.handle.net/10361/18081

Antzeko izenburuak

A review on potential of PARP inhibitors in the treatment of prostate cancer
nork: Islam, Saidul
Argitaratua: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
nork: Jahan, Nusrat
Argitaratua: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
nork: Flora, Sanzida Alam
Argitaratua: (2024)

Immunotherapy in the Management of Lung Cancer
nork: Tasnim, Humayra
Argitaratua: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
nork: Ratu, Tabassum
Argitaratua: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
nork: Emon, Kamrul Hasan
Argitaratua: (2022)

Identification of FAP inhibitors using in silico simulation study
nork: Deeba, Maliha Tasnim
Argitaratua: (2018)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
nork: Oshin, Sadia Afrin
Argitaratua: (2021)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
nork: Karim, Azrin
Argitaratua: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
nork: Mirza, Maisa Tasnim
Argitaratua: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
nork: Khan, Muidul Hasan
Argitaratua: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
nork: Haque, Mushfiqul
Argitaratua: (2019)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
nork: Islam, Nahidul
Argitaratua: (2023)

A review on targeted therapies for lung cancer
nork: Ashraf, Anushey
Argitaratua: (2023)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
nork: Afroza, Halima
Argitaratua: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
nork: Ishrat, Nowshin
Argitaratua: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
nork: Sorno, Rubina Haque
Argitaratua: (2024)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
nork: Mahin, Md. Tamjidur Rahman
Argitaratua: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
nork: Alam, Kazi Tasnuva
Argitaratua: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
nork: Fred, Namanda Rogers
Argitaratua: (2021)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
nork: Khandker, Tahia Anjum
Argitaratua: (2024)

Synthesis and sar o acne medication
nork: Naureen, Tasnia
Argitaratua: (2024)

HPLC method development for the analysis of linagliptin
nork: Mimiya, Ruhani Amrin
Argitaratua: (2020)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
nork: Paul, Pulock
Argitaratua: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
nork: Kamal, Tasnova
Argitaratua: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
nork: Tania, Umme
Argitaratua: (2023)

Trend in approval of targeted biologics in the last two decades
nork: Siddika, Khadiza
Argitaratua: (2024)

Breast cancer therapy through Liposomal drug delivery system
nork: Ome, Nusrat Jahan
Argitaratua: (2024)

Epigenetic therapy in cancer
nork: Abid, Md. Shadman Ridwan
Argitaratua: (2021)

A review on triple-negative breast cancer and its potential treatment
nork: Niasa, Jannatul Ferdous
Argitaratua: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
nork: Razna, Amrin Islam
Argitaratua: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
nork: Chakraborty, Anuradha
Argitaratua: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
nork: Nahar, Kamrun
Argitaratua: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
nork: Nashrah, Zannatul
Argitaratua: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
nork: Hoque, Syeda Mehren
Argitaratua: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
nork: Parvez, Safi
Argitaratua: (2023)

Statistics and informatics in molecular cancer research

A comprehensive review on drug repurposing in cancer treatment
nork: Sarkar, Onusree
Argitaratua: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
nork: Hasan, Amit
Argitaratua: (2024)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
nork: Dowla, Rumana, et al.
Argitaratua: (2022)